He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment
Triggering global regulatory submissions this year for the treatment of obesity
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
The company has improved access to quality healthcare for seniors across both urban and rural areas
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
Subscribe To Our Newsletter & Stay Updated
